Nemaura Medical (NMRD +8.9%) has commissioned the integration of data from third party wearable devices into its proBEAT app which is planned for launch in the U.S. later this year.
proBEAT is a wearable non-invasive glucose monitor designed to collect glucose profiles and develop artificial intelligence-based prompts and feedback to users affecting their blood glucose levels.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.